BLR&D Research Career Scientist Award Application
BLR
基本信息
- 批准号:10047693
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-10-01 至 2025-09-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdministrative SupplementAffectAmericanAmerican Heart AssociationAnimal ModelAnimalsAppointmentAwardBiologyBlood VesselsBlood flowBrainBrain DiseasesCardiometabolic DiseaseCardiovascular DiseasesCerebrovascular DisordersCerebrovascular systemCerebrumChronicCoagulation ProcessCollaborationsComplications of Diabetes MellitusDementiaDiabetes MellitusDiseaseDisease modelEndocrinologyExtramural ActivitiesFailureFemaleFundingGrantHealthcareHypertensionImpaired cognitionImpairmentInjuryInterventionIschemic Brain InjuryIschemic StrokeJournalsMentorsMicrovascular DysfunctionMissionMolecularNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Neurological Disorders and StrokeNeuronsPaperPathologicPatientsPatternPericytesPharmaceutical PreparationsPharmacologyPhysiologyPostdoctoral FellowProcessProgram Research Project GrantsPublicationsPublishingQuality of lifeRecoveryRecovery of FunctionResearchResearch PersonnelRiskRisk FactorsRoleScientistSenior ScientistSocietiesStrokeStructureSystemTrainingTraining ProgramsUnited States Department of Veterans AffairsUnited States National Institutes of HealthUniversitiesVeteransWagesWomen&aposs Healthacute strokearteriolebrain repaircareercognitive recoverydementia riskdiabeticdisabilityimprovedinjury recoveryinnovationischemic injuryjuvenile animalmalemilitary veteranmultidisciplinaryneovascularizationnext generationpeerpost strokepost stroke cognitive impairmentprofessorprogramsrepairedsexstroke patientstroke recoverystroke therapysuccessvascular injuryvascular risk factorworking group
项目摘要
Stroke is the number one cause of disability in the US. This is a result of physical impairments as well as
increased risk of dementia after stroke. High blood pressure is the top risk factor for stroke followed by
diabetes. High blood pressure, diabetes and stroke are highly prevalent in our Veterans. Hypertension is the
most common vascular risk factor among Veterans with stroke. Moreover, among Veterans, hypertension is
the most common chronic condition, affecting more than 37% of the Veteran population. 25% of our Veterans
have diabetes. Despite years of extensive research, all efforts to protect neurons from ischemic stroke injury
failed. There is only one treatment for stroke and that is to open the occluded blood vessels with a clot-busting
drug. There is NO treatment for dementia that develops after stroke. Reasons for this failure may be several
fold: 1) researchers have used otherwise healthy and young animal models in research; 2) most studies
utilized male animals; and 3) researchers have tried to salvage and repair only "neurons". It is now increasingly
recognized that blood vessels of the brain are extremely critical for the acute stroke injury and chronic
recovery. When blood flow to the brain is compromised, cognitive impairment ensues and recovery from stroke
is impaired. Targets for new treatments may be different in females and/or diseases like diabetes and high
blood pressure that are commonly found in patients with stroke or cognitive impairment. This is also quite
relevant to VA mission as our female Veterans are steadily increasing among our Veterans and suffering from
these diseases necessitating the VA to launch the “Women’s Health Initiative”. Dr. Ergul, a well-accomplished
VA Research Career Scientist and Regents’ Professor at Augusta University, uses her uniquely combined
expertise in endocrinology, physiology, pharmacology and vascular biology to address these gaps by studying
the interaction of diabetes and high blood pressure with associated complications such as stroke and cognitive
impairment in both sexes. She is extremely committed to improve the quality of life of our Veterans and our
society, a commitment solidified by Research Career Scientist recognition in the last 5 years. Her commitment
to VA and cardiovascular disease research is evidenced by 1) continuous extramural finding by National
Institutes of Health, American Heart Association, American Diabetes Association, and Veterans Affairs in the
last 20 years, 2) her over 150 publications (59 alone during the tenure of the RCS in the last 5 years), 3)
success of renewing VA Merit Award twice during the current RCS award period, 4) receiving additional
extramural funding to address complementary scientific questions, 5) her stature as a leader in the field and 6)
the success of her mentoring next generation of scientists.
中风是美国导致残疾的第一大原因,这是由身体损伤和身体损伤造成的。
中风后痴呆的风险增加 高血压是中风的首要危险因素,其次是中风。
高血压、糖尿病和中风在我们的退伍军人中非常普遍。
此外,在退伍军人中,高血压是中风最常见的血管危险因素。
最常见的慢性病,影响超过 37% 的退伍军人(占我们退伍军人的 25%)。
尽管进行了多年的广泛研究,但仍努力保护神经元免受缺血性中风损伤。
治疗中风的方法只有一种,那就是通过溶栓术打开闭塞的血管。
中风后发生的痴呆症尚无治疗方法,其原因可能有多种。
折叠:1)研究人员在研究中使用了其他健康和年轻的动物模型;2)大多数研究
利用雄性动物;3)研究人员尝试仅挽救和修复“神经元”。
认识到大脑血管对于急性中风损伤和慢性中风损伤极为关键
当流向大脑的血液受到损害时,认知障碍就会随之而来,中风也会随之恢复。
女性和/或糖尿病和高血压等疾病的新治疗目标可能有所不同。
中风或认知障碍患者中常见的血压也相当高。
与退伍军人事务部的使命相关,因为我们的女性退伍军人在退伍军人中稳步增加,并遭受
这些疾病迫使退伍军人事务部发起“妇女健康倡议”,埃尔古尔博士是一位卓有成效的人。
VA 研究职业科学家和奥古斯塔大学摄政教授,利用她独特的结合
内分泌学、生理学、药理学和血管生物学方面的专业知识,通过研究来弥补这些差距
糖尿病和高血压与中风和认知等相关并发症的相互作用
她非常致力于改善我们退伍军人和我们的生活质量。
过去 5 年来,研究职业科学家的认可巩固了她的承诺。
VA 和心血管疾病研究的证据是 1) 国家连续的校外发现
健康研究所、美国心脏协会、美国糖尿病协会和退伍军人事务部
过去 20 年,2) 她发表了 150 多篇出版物(仅在过去 5 年 RCS 任期内就有 59 篇),3)
在当前 RCS 奖励期内成功续订 VA 优异奖两次,4) 获得额外奖励
用于解决补充科学问题的校外资金,5) 她作为该领域领导者的地位,以及 6)
她指导下一代科学家的成功。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ADVIYE ERGUL其他文献
ADVIYE ERGUL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ADVIYE ERGUL', 18)}}的其他基金
ShEEP Request for Noldus EthoVision XT System
ShEEP 请求 Noldus EthoVision XT 系统
- 批准号:
10534037 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Progressive Post Stroke Cognitive Impairment:Mechanisms & Intervention
进行性中风后认知障碍:机制
- 批准号:
10237897 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Progressive Post Stroke Cognitive Impairment:Mechanisms & Intervention
进行性中风后认知障碍:机制
- 批准号:
10468083 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Progressive Post Stroke Cognitive Impairment:Mechanisms & Intervention
进行性中风后认知障碍:机制
- 批准号:
10011890 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
- 批准号:
9429297 - 财政年份:2017
- 资助金额:
-- - 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
- 批准号:
10541346 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
- 批准号:
9217676 - 财政年份:2014
- 资助金额:
-- - 项目类别:
Vascular Injury and Recovery in Diabetic Ischemic Stroke
糖尿病缺血性中风的血管损伤和恢复
- 批准号:
8848660 - 财政年份:2014
- 资助金额:
-- - 项目类别:
相似海外基金
Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society
下一代本土遗传学、伦理学和社会研究人员的培训和提升计划
- 批准号:
10841760 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Improving identification and healthcare for patients with Inherited Cancer Syndromes: Evidence-based EMR implementation using a web-based computer platform
改善遗传性癌症综合征患者的识别和医疗保健:使用基于网络的计算机平台实施基于证据的 EMR
- 批准号:
10831647 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Identifying how alcohol-evoked changes in neural firing affect systems level computations during decision-making
确定酒精引起的神经放电变化如何影响决策过程中的系统级计算
- 批准号:
10766877 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Bioethical Issues Associated with Objective Behavioral Measurement of Children with Hearing Loss in Naturalistic Environments
与自然环境中听力损失儿童的客观行为测量相关的生物伦理问题
- 批准号:
10790269 - 财政年份:2023
- 资助金额:
-- - 项目类别:
South Carolina Clinical & Translational Research Institute (SCTR)
南卡罗来纳州临床
- 批准号:
10820346 - 财政年份:2023
- 资助金额:
-- - 项目类别: